US Patent 11447771 CRISPR DNA targeting enzymes and systems
Patent 11447771 was granted and assigned to Arbor Biotechnologies on September, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David A. Scott0
David R. Cheng0
Winston X. Yan0
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+415 characters)
US Patent 11447771 CRISPR DNA targeting enzymes and systems
Article
The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR-Cas systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114477710
Date of Patent
September 20, 2022
0Patent Application Number
175066270
Date Filed
October 20, 2021
0Patent Primary Examiner
Find more entities like US Patent 11447771 CRISPR DNA targeting enzymes and systems
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
